Generated by Meeveem AI
"Global specialty pharmaceutical company creating life-changing treatments for rare diseases."
Kyowa Kirin is a Japan-based global specialty pharmaceutical company discovering innovative medicines through advanced biotechnology. Focusing on bone and mineral diseases, intractable hematological conditions, and rare diseases, the company uses antibody technologies and gene therapy to address unmet medical needs for patients requiring specialised treatment. Operating across more than 50 markets with over 5,600 employees, Kyowa Kirin combines disease science with drug discovery technology. The patient-centric approach involves listening to patients and medical professionals to develop solutions quickly. With over 70 years of heritage, Kyowa Kirin delivers life-changing value to people facing serious and rare diseases.
5669
Team Members
1949
Founded
Pharma
Sector
Hybrid
Work Environment
A world where innovative medicines bring smiles to patients living with rare and serious diseases, transforming their quality of life through breakthrough biotechnology.
The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.